Why the study?
Does comprehensive risk stratification at early follow-up determine prognosis in patients with pulmonary arterial hypertension?
Does comprehensive risk stratification at early follow-up determine prognosis in patients with pulmonary arterial hypertension?
Comprehensive risk assessments at early follow-up are valid for determining prognosis in pulmonary arterial hypertension.
No takes yet. Share an insight, caveat, or question.
Supports early comprehensive risk assessment in PAH; leaves open prospective validation of targeting low-risk profiles.
Kylhammar et al. (2017) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: